about
Spotlight on ixazomib: potential in the treatment of multiple myelomaRenal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma.Long-term effects and psychological adjustment: study protocol of a large register-based study on quality of life among survivors of hematological malignancies.Biology of colorectal cancer.11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.Multiple Myeloma: Treatment is Getting IndividualizedA CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells.Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple MyelomaSmall interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study.Bortezomib-induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation.3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.Apoptotic effects of non-edible parts of Punica granatum on human multiple myeloma cells.Systemic modeling myeloma-osteoclast interactions under normoxic/hypoxic condition using a novel computational approachNanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival.Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.Hypoxia promotes stem cell-like phenotype in multiple myeloma cells.Histone deacetylase inhibitor NaBut suppresses cell proliferation and induces apoptosis by targeting p21 in multiple myeloma.Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma.Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.Identification of a novel c-Myc inhibitor with antitumor effects on multiple myeloma cells
P2860
Q26774440-E89B6BAB-8DB0-4F8C-A330-060189196731Q30275870-14A5039F-C20D-4D1B-AF8C-8D09279E7E66Q33868512-ACBF1B3E-49BB-4C61-9B74-5F49C68368D2Q33901198-131F9B95-B9DB-4C0D-A968-E23B2F55D9E3Q34669618-4FAA44EC-E60B-4340-80D2-14B273D90076Q35781619-14886C52-5FC8-4634-9E33-6EFAAA74628DQ36522964-9B89D355-0483-48D2-8CFD-24DDFDAB1E41Q37032148-30595CED-6E26-4BCA-9715-D569581E03DFQ37085867-813CDC69-5E11-409C-98B5-33FD06E13222Q37210703-11C80CBF-ACEF-4722-937C-E1F1B12340F0Q37471806-5014D92D-4877-4945-A9DC-724A27E19C03Q37644930-CD3ABAA9-28AF-4141-B866-003E19100374Q38832888-F18E5576-F8F4-439D-9013-368C890BF381Q38839835-C811CD90-1A78-4D47-BFFC-8B6D9834EFDCQ38843122-E6148FDA-C598-4772-B71B-C9DCA169A1C2Q39139112-70DFBDA3-F008-433A-9223-82DA23F4C4F8Q41091865-49BA874D-C145-41E8-BEF2-1E98F3078F5DQ41770950-D21F12E1-46CC-46FB-AB94-6F3AD0297959Q42598619-2BAE1C34-34C9-4C55-9517-586A0C3AF784Q43130078-5CC755C9-EBA7-45B9-AEB0-81A6584BA017Q47175684-698027DB-CBB6-4C52-8F1B-8E209C1CA2A0Q48073647-0409222A-CD31-4A18-8E6B-7AD7B62A6EA6Q49358494-17EC6780-31FE-4D4D-B9C0-9EA3EF9A8F15Q58719353-B23B6E46-27B6-4694-A870-8B717CC971E6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecularly targeted therapies in multiple myeloma
@en
type
label
Molecularly targeted therapies in multiple myeloma
@en
prefLabel
Molecularly targeted therapies in multiple myeloma
@en
P2860
P50
P356
P1476
Molecularly targeted therapies in multiple myeloma
@en
P2093
P2860
P304
P356
10.1155/2014/976567
P577
2014-04-16T00:00:00Z